Novel vasopressin type 2 (AVPR2) gene mutations in Brazilian nephrogenic diabetes insipidus patients
- PMID: 17020465
- DOI: 10.1089/gte.2006.10.157
Novel vasopressin type 2 (AVPR2) gene mutations in Brazilian nephrogenic diabetes insipidus patients
Abstract
Nephrogenic diabetes insipidus (NDI) is an inherited disorder characterized by renal resistance to the antidiuretic effect of arginine vasopressin (AVP), resulting in polyuria, polydipsia, and hypoosmolar urine. In the vast majority of cases, NDI is associated with germ-line mutations in the vasopressin receptor type 2 gene (AVPR2) and in about 8% of the cases with the water channel aquaporin-2 gene (AQP-2) mutations. To date, approximately 277 families with 185 germ-line mutations in the AVPR2 gene have been described worldwide. In the present study, the AVPR2 gene was genotyped in eight unrelated Brazilian kindred with NDI. In five of these NDI families, novel mutations were noted (S54R, I130L, S187R, 219delT, and R230P), whereas three seemingly unrelated probands were found to harbor previously described AVPR2 gene mutations (R106C, R137H, R337X). Additionally a novel polymorphism (V281V) was detected. In conclusion, although NDI is a rare disease, the findings of mutations scattered over the entire coding region of the AVPR2 gene are a valuable model to determine structure function relationship in G-protein-coupled receptor related diseases. Furthermore, our data indicate that in Brazil the spectrum of AVPR2 gene mutations is "family specific".
Similar articles
-
AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus.Kidney Int. 1998 Dec;54(6):1909-22. doi: 10.1046/j.1523-1755.1998.00214.x. Kidney Int. 1998. PMID: 9853256
-
Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature.Metabolism. 2012 Jul;61(7):922-30. doi: 10.1016/j.metabol.2012.01.005. Epub 2012 Mar 3. Metabolism. 2012. PMID: 22386940 Review.
-
Identification of mutations in the arginine vasopressin receptor 2 gene causing nephrogenic diabetes insipidus in Chinese patients.J Hum Genet. 2002;47(2):66-73. doi: 10.1007/s100380200002. J Hum Genet. 2002. PMID: 11916004
-
Nephrogenic diabetes insipidus.Adv Chronic Kidney Dis. 2006 Apr;13(2):96-104. doi: 10.1053/j.ackd.2006.01.006. Adv Chronic Kidney Dis. 2006. PMID: 16580609 Review.
-
A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers.Eur J Pediatr. 2016 May;175(5):727-33. doi: 10.1007/s00431-015-2684-4. Epub 2016 Jan 21. Eur J Pediatr. 2016. PMID: 26795631 Free PMC article.
Cited by
-
Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.Eur J Pediatr. 2015 Oct;174(10):1373-85. doi: 10.1007/s00431-015-2534-4. Epub 2015 Apr 23. Eur J Pediatr. 2015. PMID: 25902753
-
V2 vasopressin receptor (V2R) mutations in partial nephrogenic diabetes insipidus highlight protean agonism of V2R antagonists.J Biol Chem. 2012 Jan 13;287(3):2099-106. doi: 10.1074/jbc.M111.268797. Epub 2011 Dec 5. J Biol Chem. 2012. PMID: 22144672 Free PMC article.
-
Four Japanese Patients with Congenital Nephrogenic Diabetes Insipidus due to the AVPR2 Mutations.Case Rep Pediatr. 2018 Jul 3;2018:6561952. doi: 10.1155/2018/6561952. eCollection 2018. Case Rep Pediatr. 2018. PMID: 30073107 Free PMC article.
-
Nephrogenic diabetes insipidus (NDI): clinical, laboratory and genetic characterization of five Brazilian patients.Clinics (Sao Paulo). 2009 May;64(5):409-14. doi: 10.1590/s1807-59322009000500007. Clinics (Sao Paulo). 2009. PMID: 19488606 Free PMC article.
-
Identification of a Novel Arginine Vasopressin Receptor 2 Mutation (p.V183M) in a Chinese Family with Nephrogenic Diabetes Insipidus.Mol Syndromol. 2020 Jul;11(3):130-134. doi: 10.1159/000507035. Epub 2020 Mar 28. Mol Syndromol. 2020. PMID: 32903920 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Miscellaneous